[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BioValues Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::153957211.png) @BioValues BioValues

BioValues posts on X about $bcab, $incy, $exel, $jspr the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::153957211/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153957211/c:line/m:interactions.svg)

- X Week XXXXXX +9.30%
- X Month XXXXXXX +55%
- X Months XXXXXXX +100%
- X Year XXXXXXX +244%

### Mentions: X [#](/creator/twitter::153957211/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153957211/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX +42%
- X Months XXX +127%
- X Year XXX +140%

### Followers: XXXXX [#](/creator/twitter::153957211/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153957211/c:line/m:followers.svg)

- X Week XXXXX +0.25%
- X Month XXXXX +0.78%
- X Months XXXXX +7.30%
- X Year XXXXX +14%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::153957211/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::153957211/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  XXX% [technology brands](/list/technology-brands)  XXX%

**Social topic influence**
[$bcab](/topic/$bcab) #1, [$incy](/topic/$incy) #2, [$exel](/topic/$exel) #1, [$jspr](/topic/$jspr) 7.41%, [$cldx](/topic/$cldx) 7.41%, [$prld](/topic/$prld) 3.7%, [before dec](/topic/before-dec) 3.7%, [dec](/topic/dec) 3.7%, [$mrsn](/topic/$mrsn) 3.7%, [bode](/topic/bode) XXX%

**Top accounts mentioned or mentioned by**
[@streetcred2017](/creator/undefined) [@investorclimber](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@stmkrs](/creator/undefined) [@peterpaone](/creator/undefined) [@richardtip17589](/creator/undefined) [@jul05310473john](/creator/undefined) [@polycle](/creator/undefined) [@lucy3370](/creator/undefined) [@shitcosavant](/creator/undefined) [@peter_paone](/creator/undefined)

**Top assets mentioned**
[Incyte Corporation (INCY)](/topic/$incy) [Exelixis Inc (EXEL)](/topic/$exel) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Dawn Protocol (DAWN)](/topic/$dawn) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax)
### Top Social Posts
Top posts by engagements in the last XX hours

"$BCAB obviously a lot of different potential partners out there (big or mid-cap) but maybe just maybe (ChatGPT's prediction for mid-cap) $EXEL:"  
[X Link](https://x.com/BioValues/status/1996612888589734144)  2025-12-04T16:09Z 8885 followers, 1307 engagements


"$BCAB should know who the partner is within X weeks of today. Been chatting with GROK and it seems convinced that EXEL (ChatGTP #1) or INCY (its #1) are the top contenders based on the HPV+ focus (see below). $INCY has been very vocal on doing deals and just did one with $PRLD"  
[X Link](https://x.com/BioValues/status/1996972553437601973)  2025-12-05T15:58Z 8885 followers, 2661 engagements


"$BCAB if it's $EXEL the deal should be announced early next week ahead of their Wed R/D day. If nothing then $INCY likely top contender at any second before Dec 19"  
[X Link](https://x.com/BioValues/status/1996974957344276481)  2025-12-05T16:08Z 8885 followers, 1513 engagements


"$BCAB - $MRSN ADC buyout by $DAWN continues to bode well for BCAB's own deal prospects in a booming biotech market. Guidance is for a deal before end of year. Ironically BCAB also has its own preclinical B7-H7 asset. Will look for any hints at today's CC"  
[X Link](https://x.com/BioValues/status/1988962705802424498)  2025-11-13T13:30Z 8880 followers, 2087 engagements


"$BCAB ChatGPT prediction and a slide from $EXEL's Nov earnings. Let's see"  
[X Link](https://x.com/BioValues/status/1989336830995792254)  2025-11-14T14:17Z 8882 followers, 1048 engagements


"$JSPR by far my top pick for Q1 2026. $40M market cap $50M cash and data that could revalue the company towards $CLDX (even a tiny slice is multiples from here). Not even factoring in the asthma upside either. Thanks for the cheap shares"  
[X Link](https://x.com/BioValues/status/1996245648539304334)  2025-12-03T15:50Z 8883 followers, 1815 engagements


"$JSPR so essentially the January bar to beat is $CLDX data. Equal or better efficacy to $CLDX with a BETTER safety profile"  
[X Link](https://x.com/BioValues/status/1996312510249787714)  2025-12-03T20:16Z 8884 followers, XXX engagements


"$BCAB I know a ton of skeptics on their guidance of a deal getting done before end of year (2 weeks left) but this is the kind of biotech market where deals get done vs XBI at XX. Going to be an eventful next week or so"  
[X Link](https://x.com/BioValues/status/1996611516247019959)  2025-12-04T16:04Z 8881 followers, 1743 engagements


"If only I had held X years $prax:"  
[X Link](https://x.com/BioValues/status/1996697202337763445)  2025-12-04T21:44Z 8880 followers, 7597 engagements


"$BCAB - $INCY I will say I took a listen to their investor presentations this week and they said business development for oncology will be part of their strategy. So GROK very well could be right here"  
[X Link](https://x.com/BioValues/status/1996973095983178159)  2025-12-05T16:01Z 8881 followers, 1336 engagements


"$BCAB two more deals announced this morning (private bios with Novartis/Pfizer). Now in the final stretch for deals to be announced before Xmas week/EOY. So gives $BCAB X trading days to issue PR. If not $EXEL tomorrow then $INCY #1 pick for next week"  
[X Link](https://x.com/BioValues/status/1998410009311629662)  2025-12-09T15:10Z 8885 followers, 2026 engagements